Experiences from six years of quality assured Model of End Stage Liver Disease (MELD) diagnostics.
<h4>Background</h4>The model of end-stage liver disease (MELD) score was established for the allocation of liver transplants. The score is based on the medical laboratory parameters: bilirubin, creatinine and the international normalized ratio (INR). A verification algorithm for the labo...
        Guardado en:
      
    
                  | Autores principales: | Pascal Hunold, Thomas Berg, Daniel Seehofer, Robert Sucher, Adam Herber, Berend Isermann, Joachim Thiery, Thorsten Kaiser | 
|---|---|
| Formato: | article | 
| Lenguaje: | EN | 
| Publicado: | 
        
      Public Library of Science (PLoS)    
    
      2021
     | 
| Materias: | |
| Acceso en línea: | https://doaj.org/article/baf9ed71c9b54be293dc592ecf794e10 | 
| Etiquetas: | 
       Agregar Etiqueta    
     
      Sin Etiquetas, Sea el primero en etiquetar este registro!
   
 | 
Ejemplares similares
- 
                
        
          Raman spectroscopy on blood serum samples of patients with end-stage liver disease.        
                  
por: René Staritzbichler, et al.
Publicado: (2021) - 
                
        
          Clinical applications of the Model for End-Stage Liver Disease (MELD) in hepatic medicine        
                  
por: Lau T, et al.
Publicado: (2013) - 
                
        
          Beyond MELD Predictors of Post TIPSS Acute Liver Failure the Lesson Learned        
                  
por: Ritu Verma, et al.
Publicado: (2021) - 
                
        
          MELD-accelerated molecular dynamics help determine amyloid fibril structures        
                  
por: Bhanita Sharma, et al.
Publicado: (2021) - 
                
        
          Role of MELD score and serum creatinine as prognostic tools for the development of acute kidney injury after liver transplantation.        
                  
por: Thiago Gomes Romano, et al.
Publicado: (2013)